Curcumin's Role in Targeting Glycolysis in Prostate Cancer Cells
Author Information
Author(s): Dongsic Choi, Jun Gi Lee, Su-Hak Heo, Moon-Kyen Cho, Hae-Seon Nam, Sang-Han Lee, Yoon-Jin Lee
Primary Institution: Soonchunhyang University
Hypothesis
Can curcumin effectively target the glycolytic behavior of lactate-acclimated prostate carcinoma cells to improve sensitivity to docetaxel?
Conclusion
Curcumin may enhance treatment outcomes in prostate cancer by targeting glycolysis and overcoming docetaxel resistance.
Supporting Evidence
- Curcumin combined with docetaxel reduced tumor size and weight in a xenograft model.
- Lactate-acclimated prostate cancer cells showed increased growth and reduced sensitivity to docetaxel.
- HK2 knockdown led to decreased cell growth and increased apoptosis in prostate cancer cells.
- Curcumin's anti-glycolytic effects were consistent across 2D and 3D culture models.
Takeaway
Curcumin helps fight prostate cancer by making cancer cells less resistant to a common drug called docetaxel, which usually doesn't work well on these cells.
Methodology
The study involved cell culture experiments, Western blotting, and xenograft models to assess the effects of curcumin on prostate cancer cells.
Potential Biases
Potential bias due to the use of specific cell lines and the controlled laboratory environment.
Limitations
The study primarily focused on specific prostate cancer cell lines and may not fully represent all prostate cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website